Kangqian Biology (688526.SH) released its performance for the first half of the year, with a net profit attributable to shareholders of 2.2 billion yuan, an increase of 44.09%.

Financial news from the Wise Finance APP, Keqian Biology (688526.SH) released its semi-annual report for 2025, with the company's operating income reaching 487 million yuan, a year-on-year increase of 21.67%. The net profit attributable to the shareholders of the listed company was 220 million yuan, a year-on-year increase of 44.09%. The net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 190 million yuan, a year-on-year increase of 43.12%. The basic earnings per share were 0.47 yuan. Due to the improvement in the market conditions, the company's sales volume increased, leading to an increase in revenue.